ロード中...
Drug repurposing for COVID-19: Approaches, challenges and promising candidates
Traditional drug development and discovery has not kept pace with threats from emerging and re-emerging diseases such as Ebola virus, MERS-CoV and more recently, SARS-CoV-2. Among other reasons, the exorbitant costs, high attrition rate and extensive periods of time from research to market approval...
保存先:
| 出版年: | Pharmacol Ther |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier Inc.
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8220862/ https://ncbi.nlm.nih.gov/pubmed/34174275 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pharmthera.2021.107930 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|